Hydrofarm Group (HYFM) Q2 2024 earnings summary

Executive summary

• Net sales declined 13.1% year-over-year to $54.8 million, mainly due to lower volume/mix and pricing declines from cannabis industry oversupply.

• Gross profit margin fell to 19.8% from 23.0% year-over-year; adjusted gross profit margin decreased to 24.4% from 27.0%.

• Net loss widened to $23.5 million from $12.9 million, primarily due to an $11.5 million non-cash loss on the IGE Asset Sale.

• Restructuring and cost-saving initiatives led to a 20% reduction in SG&A expenses, supporting positive adjusted EBITDA for the fourth time in five quarters.

• Cash and cash equivalents stood at $30.3 million as of June 30, 2024, with no borrowings under the revolving credit facility.

Financial highlights

• Q2 2024 net sales: $54.8 million (down 13.1% year-over-year); six months: $109.0 million (down 13.0%).

• Adjusted gross profit was $13.3 million (24.4% of net sales), down from $17 million (27%) last year.

• Adjusted EBITDA was $1.7 million, compared to $2.5 million in the prior year period.

• Free cash flow for Q2 was $3.4 million, with operating cash flow of $3.8 million and capex of $0.4 million.

• Principal balance on term loan was $120.2 million; $20 million available on revolving credit facility.

Outlook and guidance

• Reaffirmed 2024 outlook: net sales to decrease low to high teens percent, positive adjusted EBITDA and free cash flow expected.

• Capital expenditures guidance lowered to $3.5–$4.5 million for 2024.

• Expects stronger profitability in Q3 than Q4 due to seasonality, with overall margin expansion anticipated in the second half.

• Additional restructuring charges in the second half of 2024 may exceed $2 million; annual cost savings from restructuring estimated at over $2 million.

• Anticipates improved year-over-year adjusted gross profit margin from cost savings and minimal non-restructuring charges.